NCT05348811 2026-01-06HAIC Combined With Donafenib and Sintilimab for Unresectable ICCZhongda HospitalPhase 2 Completed25 enrolled
NCT05262959 2024-08-13A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCCShanghai Zhongshan HospitalPhase 2 Completed30 enrolled